Clinical trial

Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa

NCT00310791 · Boston Children's Hospital, Other · Completed

Key facts

NCT number NCT00310791
Title Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa
Official title Effects of Adrenal and Gonadal Hormone Replacement in Young Women With Anorexia Nervosa
Lead sponsor Boston Children's Hospital, Other
Collaborators United States Department of Defense U.S. Fed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH
Status Completed
Phase Phase 2/Phase 3
Study type Interventional
Conditions Anorexia Nervosa
Intervention type Drug, Other
Interventions Hormone replacement therapy (estrogen/progestin), Placebo (Sugar Pill), Dehydroepiandrosterone (DHEA)
Enrollment 80
Start date Apr 1, 2004
Primary completion Oct 1, 2009
Completion Dec 1, 2010
First posted Apr 5, 2006
Last update posted Apr 11, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies